Answer
Cabozantinib should not be used during pregnancy unless the woman’s clinical condition requires it; there are no studies in pregnant women, animal studies showed embryo-foetal and teratogenic effects, and the potential human risk is unknown.
Sources for this answer
- COMETRIQ 20 & 80 mg hard capsulesIpsen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 15Document updated
Sources checked